Ontology highlight
ABSTRACT:
INSTRUMENT(S): Illumina iScan
ORGANISM(S): Homo sapiens
DISEASE(S): Tumor,Normal
SUBMITTER: Elarouci Nabila
PROVIDER: E-MTAB-3274 | ArrayExpress | 2016-02-26
REPOSITORIES: ArrayExpress
Action | DRS | |||
---|---|---|---|---|
E-MTAB-3274.idf.txt | Idf | |||
E-MTAB-3274.idf.txt_original | Idf | |||
E-MTAB-3274.raw.1.zip | Raw | |||
E-MTAB-3274.sdrf.txt | Txt |
Items per page: 5 1 - 4 of 4 |
Beuselinck Benoit B Job Sylvie S Becht Etienne E Karadimou Alexandra A Verkarre Virginie V Couchy Gabrielle G Giraldo Nicolas N Rioux-Leclercq Nathalie N Molinié Vincent V Sibony Mathilde M Elaidi Reza R Teghom Corinne C Patard Jean-Jacques JJ Méjean Arnaud A Fridman Wolf Herman WH Sautès-Fridman Catherine C de Reyniès Aurélien A Oudard Stéphane S Zucman-Rossi Jessica J
Clinical cancer research : an official journal of the American Association for Cancer Research 20150112 6
<h4>Purpose</h4>Selecting patients with metastatic clear-cell renal cell carcinoma (m-ccRCC) who might benefit from treatment with targeted tyrosine kinase inhibitors (TKI) is a challenge. Our aim was to identify molecular markers associated with outcome in patients with m-ccRCC treated with sunitinib.<h4>Experimental design</h4>We performed global transcriptome analyses on 53 primary resected ccRCC tumors from patients who developed metastatic disease and were treated with first-line sunitinib. ...[more]